A novel entry to the vitamin D triene system
- 31 December 1992
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 33 (49) , 7589-7592
- https://doi.org/10.1016/s0040-4039(00)60832-8
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Studies of vitamin D (calciferol) and its analogs. 39. Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogs of 1.alpha.,25-dihydroxyvitamin D3Journal of Medicinal Chemistry, 1991
- Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolismBlood, 1991
- Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites: A comparative study with 1,25(OH)2D3Biochemical Pharmacology, 1991
- 1α,25-dihydroxy-19-nor-vitamin D3, a novel vitamin D-related compound with potential therapeutic activityTetrahedron Letters, 1990
- Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilizationBlood, 1989
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- Triply convergent synthesis of 1.alpha.,25-dihydroxy-24(R)-fluorocholecalciferolThe Journal of Organic Chemistry, 1988
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- Stereoselective total synthesis of 1.alpha.,25-dihydroxycholecalciferolJournal of the American Chemical Society, 1982